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Abstract
Background
Tuberculosis in Zambia is a major public health problem, however the country does not
have reliable baseline data on the TB prevalence for impact measurement; therefore it was
among the priority countries identified by the World Health Organization to conduct a
national TB prevalence survey
Objective
To estimate the prevalence of tuberculosis among the adult Zambian population aged 15
years and above, in 2013–2014.
Methods
A cross-sectional population-based survey was conducted in 66 clusters across all the 10
provinces of Zambia. Eligible participants aged 15 years and above were screened for TB
symptoms, had a chest x-ray (CXR) performed and were offered an HIV test. Participants
with TB symptoms and/or CXR abnormality underwent an in-depth interview and submitted
PLOSONE | DOI:10.1371/journal.pone.0146392 January 15, 2016 1 / 14
OPEN ACCESS
Citation: Kapata N, Chanda-Kapata P, Ngosa W,
Metitiri M, Klinkenberg E, Kalisvaart N, et al. (2016)
The Prevalence of Tuberculosis in Zambia: Results
from the First National TB Prevalence Survey, 2013–
2014. PLoS ONE 11(1): e0146392. doi:10.1371/
journal.pone.0146392
Editor: Kebede Deribe, Brighton and Sussex Medical
School, UNITED KINGDOM
Received: June 24, 2015
Accepted: December 16, 2015
Published: January 15, 2016
Copyright: This is an open access article, free of all
copyright, and may be freely reproduced, distributed,
transmitted, modified, built upon, or otherwise used
by anyone for any lawful purpose. The work is made
available under the Creative Commons CC0 public
domain dedication.
Data Availability Statement: Due to the presence of
identifying patient information, an anonymized
dataset is available upon request from the Principal
Investigator (nkapata@gmail.com).
Funding: The survey was co-funded by the
Government of the Republic of Zambia (GRZ)
through the Ministry of Health (MoH) and the United
States Government (USG) through United States
Agency for International Development—through the
TB CARE I Project/ Centres for Disease Control and
Prevention (USAID)/CDC/TB CARE I.
one spot- and one morning sputum sample for smear microscopy and liquid culture. Digital
data collection methods were used throughout the process.
Results
Of the 98,458 individuals who were enumerated, 54,830 (55.7%) were eligible to participate,
and 46,099 (84.1%) participated. Of those who participated, 45,633/46,099 (99%) were
screened by both symptom assessment and chest x-ray, while 466/46,099 (1.01%) were
screened by interview only. 6,708 (14.6%) were eligible to submit sputum and 6,154/6,708
(91.7%) of them submitted at least one specimen for examination. MTB cases identified
were 265/6,123 (4.3%). The estimated national adult prevalence of smear, culture and
bacteriologically confirmed TB was 319/100,000 (232-406/100,000); 568/100,000 (440-
697/100,000); and 638/100,000 (502-774/100,000) population, respectively. The risk of
having TB was five times higher in the HIV positive than HIV negative individuals. The TB
prevalence for all forms was estimated to be 455 /100,000 population for all age groups.
Conclusion
The prevalence of tuberculosis in Zambia was higher than previously estimated. Innovative
approaches are required to accelerate the control of TB.
Introduction
The burden of tuberculosis (TB) in Zambia is among the highest in the African region and in
2013 the prevalence was estimated at 388/100,000 population according to the World Health
Organization (WHO) and an estimated incidence rate of 427/ 100 000 population; TB is one of
the major public health problems in the country with a notification rate of 289/ 100 000 popu-
lation of all forms of TB in 2012. Zambia was one of the 22 high priority countries selected by
the World Health Organization (WHO) to undertake a national TB prevalence survey [1],
because it met the criteria as defined by the WHO Global Task Force on TB Impact Measure-
ment [2]. Historically, there have been no national TB prevalence surveys that have been con-
ducted in Zambia. Therefore, the country lacked baseline data on the prevalence of
tuberculosis disease (TB). The WHO recommends implementation of population-based preva-
lence surveys to estimate the prevalence of TB for baseline and consequently impact assessment
to measure progress [2, 3].
Currently, Zambia is relying on routine surveillance data from health facilities collected
through the national TB control program, to measure progress towards TB control targets.
This data has limitations such as under-reporting, and it does not provide information on the
number of undetected cases in the community and on those individuals seeking care outside of
the public sector. The HIV pandemic and poverty in the Country may have also led to increase
in the TB burden; furthermore, routine surveillance data may have gaps due to recording and
reporting bias [4]. Therefore, a nationally representative population-based survey was con-
ducted to estimate the burden of disease to inform policy makers and to provide baseline data
for measurement of program achievements.
The aim of the survey was to estimate the adult (15 years and older) prevalence of sputum
and culture positive pulmonary tuberculosis (PTB). The other objectives were to study the
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health seeking behaviour and the association between household income and TB disease
among the TB cases.
Materials and Methods
The study was a nationally representative cross sectional community based survey among
households in selected clusters. A sample size of approximately 54,400 adults (aged 15 years or
more) was targeted to estimate the prevalence of pulmonary TB based on the following
assumptions: Prevalence of smear-positive pulmonary TB = 199/100,000 population [5] with a
precision of 25%; a design effect of 1.5 and expected response rate of 85%.
The 66 clusters were selected in 49 districts in all the 10 provinces of Zambia. These were
randomly selected, following a two-stage probability proportion-to-size (PPS) sampling strat-
egy. The average cluster size was 825 inhabitants. The sampling frame consisted of a list of Cen-
sus Supervisory Areas (CSAs) as primary sampling units (PSUs) from all administrative areas.
Data collection was implemented using three field teams between September 2013 and July
2014. The country was zoned into three regions and each team was assigned a specific region.
In each cluster, the census team conducted household visits to register all eligible household
members, and to administer a social economic questionnaire to household heads. The elec-
tronic census register and socioeconomic questionnaire were pre-loaded on the Personal Digi-
tal Assistants (PDAs) before the field teams started to conduct the survey in the cluster.
All eligible household members (individuals meeting the inclusion criteria and who had
slept in the house during the previous 24 hours before the census team visited the households,
irrespective of nationality) were invited to a central survey site located within the cluster. The
inclusion criteria was based on individuals living in households within the selected clusters
who were 15 years or older; were able to give informed consent and had slept in the household
in the previous 24 hours prior to survey team visit. The individuals who met the exclusion cri-
teria were those aged less than 15 years or were unable to understand the information given to
them because they were deaf and a sign language interpreter was not at hand at time of recruit-
ment; or they had speech impediments and thus could not communicate; or if they were inca-
pacitated by disease such that they could not understand the information given to them.
Others who were excluded were people that were considered to be living in institutional set-
tings, such as prisons, boarding schools, military camps, Hotels and Lodges. Individuals who
were unable to provide consent or assent were also excluded.
The definitions of TB as per the national protocol were: (i) Acid fast bacilli (AFB) positive
smear which was a Fluorochrome-stained smear with at least one acid fast bacilli in 40 fields
(ii) Smear positive pulmonary TB patient was a patient with at least one specimen positive for
AFB by smear microscopy (iii) A Culture positive pulmonary TB patient was a patient with
Mycobacteria Growth indicator Tube positive showing presence of AFB and coding By Ziehl-
Neelsen (ZN) stain and identified with TAUNS (capillia) test as Mycobacterium tuberculosis
complex within the maximum incubation period of 42 days. (iv) A bacteriologically confirmed
pulmonary TB patient was a patient with smear-positive and/or culture-positive pulmonary
TB (or Xpert MTB/RIF positive). (v) New smear-positive pulmonary tuberculosis patient was a
smear-positive pulmonary TB patient having no history of treatment for tuberculosis or had
taken anti-tuberculosis drug for less than a month.
Consenting eligible participants were screened for TB symptoms using a structured ques-
tionnaire and underwent chest x-ray (CXR) screening using mobile digital CXR units to deter-
mine their eligibility to submit sputum for laboratory investigation (presumptive TB patients).
A normal chest X ray was defined as an X-ray showing clear lung fields and no abnormality
detected whereas an abnormal chest X ray was defined as one showing any lung abnormality
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(e.g. opacities, cavitation, fibrosis, pleural effusion, calcification, any unexplained or suspicious
shadow) and heart abnormalities detected on interpretation by a qualified medical officer. The
Chest X-rays were initially read in the field immediately by Medical officers and then images
were electronically transmitted to the central radiology unit at the University Teaching Hospi-
tal where they were re-read by a specialised Radiologist. They was a panel of four specialized
radiologists who were at all at post graduate level of qualification and each had at least more
than ten years’ experience involved in reading the X-rays.
The PDAs were programmed to automatically identify presumptive TB patients based on
the outcome of either the symptom-screening interview or field CXR examination. Household
members reporting to have any of the following symptoms: cough for 2 weeks, or fever
for 2 weeks, or chest pains for 2 weeks, or those with abnormal shadows on chest CXR or
indeterminate CXR findings were requested to submit two sputum samples, one on the spot
and one morning sample. After the collection in the field, the clearly labelled sputum speci-
men’s containers were sealed by tightening the screw cap and cleaning with bleach any contam-
ination on exterior of the container. Each container was packed in a zip-locked leak-proof
plastic bag with biohazard label. The sputum specimens were kept cool and stored a cool
box with ice packs and were transported to the laboratories under same conditions in a refrig-
erated cool box or one with ice packs to reduce culture contamination rates. All sputum speci-
mens were transported from the field within three or less days (five days was the maximum
transport time). A courier system was in place to ensure that the specimens were delivered
within the specified timelines. The specimens were processed within 5 days from the date of
collection.
The samples were examined for AFB smear using the Auramine-Phenol method and liquid
culture (BACTEC TM MGIT TM 960) at any of the three central reference laboratories (CRLs).
Each sample was digested and decontaminated using the Sodium Hydroxide N-acetyl-L-Cyste-
ine (4%NaOH-NALC) method and inoculated into one MGIT media and incubated in auto-
mated MGIT machines. The remaining deposits were used for concentrated AFB smear
microscopy using Fluorescent Microscopy technique. The inoculum was plated on a non-selec-
tive blood agar plate and incubated for 24 hours. The remaining inoculum was stored at 4°C
and only discarded after the outcome of the contamination check. Culture reading was per-
formed daily and confirmation of positive Mycobacteria tuberculosis growth was done by Acid
fastness on ZN stain and Capillia Test. All isolates, bothM. tuberculosis and Non-Tuberculous
Mycobacteria, were stored at -70°C.
Additionally, the Xpert MTB/RIF assay (Cepheid, Sunnyvale, CA, USA) was performed to
confirm MTB positivity for all smear positives cases. Samples from cases with culture indeter-
minate and CXR suggestive of TB were also subjected to XpertMTB/RIF assay (Xpert).
Quality assurance for AFB Smear Microscopy was conducted in such a way that all the slides
were examined by trained biomedical technical personnel meeting national AFB smear micros-
copy proficiency test standards. The slides were stored serially after examination and were pre-
pared for blinded re-checking of a random sample that was conducted at the end of each
cluster operation. A negative and positive (+1) control for every 24 slides stained was included.
Internal quality control for culture was done using the reference strain H37Rv as a positive
control and sterile phosphate buffered solution as a negative control. The controls were
included in every batch of 14 samples run. 3 ml of suspension of 0.5 McFarland’s H37Rv bacte-
rial suspension and 3 ml of sterile PBS were included in each batch of samples run. The partici-
pants who were eligible to submit sputum underwent an in-depth interview, using an
electronic structured questionnaire. After completing TB related procedures, all consenting
survey participants were also offered HIV counselling and testing on an opt-out basis. If the
participant agreed to participate, the HIV testing and counselling was conducted in accordance
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with national algorithm. Participants who consented to HIV testing had their blood collected
through a finger prick and blood was placed directly onto the screening rapid test strip (Deter-
mine™). Pre-test and post-test counselling was provided to all participants who choose to know
their results. Pre-test counselling was done prior to testing. The counselling was performed by
trained nurse counsellors. Participants had an option to be informed or not on the results of
their HIV test. If the test was non-reactive, a negative result was communicated to the partici-
pant. However, if the test was reactive, the participant was asked to give a second blood sample
from another finger prick for a confirmatory test (Uni-Gold™ Recombigen1). If the second
test was reactive, the participant was informed of the positive status, appropriately counselled
and referred for further management to the nearest health facility which was already identified
in the vicinity of each and every survey cluster. If the second test was non-reactive, the result
was considered indeterminate and the participant was advised to visit the nearest health facility
for a further testing after six weeks.
Eligible adults who failed to show up at the survey site for screening, were followed up at
household level by Community Health Volunteers (CHVs). During the follow up visit, individ-
uals found to be either very old, sick or physically incapable of going to the survey site were
transported by the survey team’s vehicle.
All cases found to have TB according to the national TB treatment guidelines were referred
to the nearest health facility for further evaluation and treatment. The survey coordinator was
responsible for notifying TB cases to the provincial and district TB officers in the clusters for
further case management.
The survey generated mostly digital data with the exception of participant invitation cards,
consent forms and hard copy QA questionnaires. A unique Personal Identification Number
(PIN) was used in all the stages of data collection and data management. The PIN was con-
verted into a barcode which were used on all forms, registers, specimen containers, results and
in digital data files to identify each survey participant.
Data files from the field (on PDAs), the CRLs and the CXR were stored electronically,
cleaned and validated separately before being merged in the final MS Access database at the
data management unit (DMU). The merge key was the PIN which had been entered in the sep-
arate data files from the field, the CRLs and the CXR by reading the barcode of the participant.
Case definition meetings were held every last week of the month to consider all cases with a
complete set of results. The case definition meetings were done making sure that all areas of
expertise were available to undertake a case-by-case review of the results so as to classify the
survey participants using a predetermined case definition framework.
Data was analysed using the STATA software package version 12. The first stage in the anal-
ysis focused on describing eligibility, enrolment and participants by age, sex, and province and
wealth tertiles. Wealth tertiles were generated by principal components analysis on a standard
list of household assets and access to basic amenities. Subsequently the outcome of screening
(interview and x-ray film) and sputum testing was described, disaggregating by key characteris-
tics namely sex, age, and type of symptoms or x-ray abnormality, setting and education level.
The core analysis focused on estimating the prevalence of pulmonary TB in the adult popula-
tion. The recommended 3-model approach as proposed by the WHO Global Task Force on
prevalence surveys was applied, in line with new guidance on best practice methods based on
Floyd et al [6].
Using a two-step approach and three different models, a robust estimate of the TB preva-
lence was made. As a first step a simple cluster level analysis was done whereby the prevalence
rates were calculated at cluster level and then combined to one single point estimate with confi-
dence boundaries. The second step was an individual level model analysis whereby three differ-
ent logistic regression models were applied, in this article only model 3 results are presented. In
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Model 3, multiple missing value imputation was done only for those eligible for sputum exami-
nation that missed data on outcome. All participants screened out were considered not having
TB. In a second step, using inverse probability weighting extrapolation was done to represent
all eligible individuals.
Ethical approval
The study protocol was cleared by the University of Zambia Biomedical Research Ethics Com-
mittee (UNZABREC) No: 020-08-12. Authority to conduct the survey was sought in line with
the existing national guidelines. Written informed consent was obtained from all individuals
who agreed to participate in the survey. For minors, both the assent of the minor and the con-
sent of the next of kin or caretakers or guardian was obtained in writing for each participant
aged 15–17 years. The institutional review board (IRB) approved this consent procedure. All
the consent or assent forms were recorded on standard forms which were developed for the
study and these were filed in lockable cabinets at the end of each cluster operation.
Results
From the initial census, 98,458 participants were enumerated in the 66 clusters. Of these,
54,830 (55.7%) were eligible to participate and 46, 099 (84.1%) participated as illustrated in
Fig 1.
There were more rural (65.2%, n = 30,042) than urban (34.8%, n = 16,057) participants. The
median age of the eligible participants was 32 years (IQR; 22 to 47) with more females (56.4%)
than males (43.6%). All the 46,099 survey participants underwent symptom screening, while
45,633 (99.0%) were screened by chest x-ray. Four hundred and sixty six (1.01%) had an inter-
view only; and 45, 633 (99%) had both interview and chest x-ray screening performed. Partici-
pants who were found to be positive on symptom screening were 4,453/46,099 (9.7%) while
3,758/45,633 (8.24%) had abnormal chest x-rays and 1,505/4,453 (33.8%) had both symptom
positive and chest x-ray abnormal.
The majority of the presumptive TB participants (CXR and Symptom) reported at least a
history of chest pains (4,653, 69.4%) followed by cough (3,708, 55.3%), night sweats (2,418,
36.0%), fever (2,375, 35.4%), sputum production (2,369, 35.3%), and weight loss (2,306,
34.4%), respectively, as shown in Fig 2.
Based on the results of the symptom and or the chest x-ray screening, 6,708 (14.6%) of the
survey participants were eligible to submit sputum sample (presumptive TB patients) for labo-
ratory investigations. Of those eligible for sputum submission, 6154 (91.7%) submitted at least
one sample; 6087/6708 (90.7%) at least spot; 4,124/6708 (61.48%) at least morning and, 4,057/
6087 (66.65%) submitted both spot and morning sample.
Out of the 6,154 (91.7%) participants who submitted at least one specimen, 265 MTB cases
were identified and defined as definite MTB cases by the expert panel. Of these, 135 (50.9%)
were smear positive and 130 (49.1%) were smear negative. 45% (118) of the cases were culture
and smear positive; 43% (113) were culture positive and smear negative; 39 (0.64%) of the 6123
available laboratory results were Xpert positive for MTB as outlined in Table 1.
The samples from 585/6708 (8.72%) participants were not processed at the laboratory
because they were either inadequate or wrong specimen.
Additionally, 61.75% (161/265) of the survey cases were symptomatic (i.e fever, cough or
chest pain lasting two weeks or more) and 82.64% (219/265) had an abnormal CXR. As shown
in Table 2, there were 97% symptomatic survey cases not on anti-TB treatment at the time of
the survey; and 49.7% of the cases that were not on treatment had sought care for their illness.
Of the 156 symptomatic TB cases not on treatment but who sought care; 93% (74) had sought
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care from a public health facility, 4% (3) from a private facility and another 4% (3) from either
a traditional healer of faith-based organization. Of the 7 TB cases (0.3%) who were already on
Fig 1. Survey data flow. CXR, Chest X-rays read; Symptom+ CXR+, Symptoms present and Chest X-ray abnormality detected; Symptom+ CXR-,
Symptoms present and Chest X-ray abnormality not detected; Symptom- CXR+, Symptoms absent and Chest X-ray abnormality detected; Symptom+ CXR
NA, Symptoms present and Chest X-ray not applicable; Symptom- CXR NA, Symptoms absent and Chest X-ray not applicable; Symptom NA CXR+,
Symptoms not applicable and Chest X-ray abnormality detected; MTB+, positive for Mycobacterium Tuberculosis; MOTT+, positive for Mycobacterium Other
Than Tuberculosis; C+, Culture positive; C-, Culture negative; S+, Sputum smear positive; S-, Sputum smear negative; XP+, Xpert MTB/RIF result positive
for MTB; CTD, Contaminated.
doi:10.1371/journal.pone.0146392.g001
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treatment, five were treated at a public facility, none at a private clinic and two from other facil-
ity. Furthermore, 15% of the survey cases reported that a member of their household had been
treated for TB before.
Non-tuberculous mycobacteria (NTM) were found in 936/6,123 (15.3%) of the individuals
whose samples were sent for culture. 13/936 individuals with NTM had MTB co-infection. Of
the 923 NTM participants without MTB, 872 were smear negative and 51 were smear positive.
Of the 46,099 TB survey participants 44,761 (97.1%) underwent HIV counselling, out of
which 30,584 (68.3%) were tested. The crude prevalence of HIV among survey participants
was 6.8% (2062/30,584).
After modelling the 265/46,099 MTB cases identified, the prevalence of smear-positive TB
was estimated at 319 per 100,000 adult population, and that of culture-positive TB was 568 per
100,000 population; while bacteriologically confirmed TB prevalence was 638 per 100,000
Fig 2. Reported signs and symptoms among presumptive TB participants. Proportions (Percentage) of
the different signs and symptoms of the presumptive TB participants.
doi:10.1371/journal.pone.0146392.g002
Table 1. Smear, Culture and Xpert MTB/Rif results (absolute numbers of available laboratory results).
XpertMTB/Rif
Smear Culture MTB (Positive) Negative Not tested Not applicable TOTAL
Positive MTB 4 2 112 0 118
MOTT 8 39 0 4 51
Negative 7 142 0 16 165
Contaminated 2 20 0 0 22
Total 21 203 112 20 356
Negative MTB 1 0 0 0 1
MOTT 3 95 n/a 4 102
Negative 9 66 n/a 5547 5622
Contaminated 5 32 n/a 5 42
Total 18 193 n/a 5556 5767
*TOTAL 39 396 112 5576 6123
MTB, Mycobacterium Tuberculosis; MOTT, Mycobacteria Other Than Tuberculosis; n/a, not applicable.
*TOTAL, Overall total of available laboratory results.
doi:10.1371/journal.pone.0146392.t001
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adult population as shown in Table 3. The prevalence of smear, culture and bacteriologically
confirmed TB was higher in males, the HIV positive, those in the age group 35–44 years and
the urban participants.
By socioeconomic status, the burden of TB was similar in the rural areas while in the urban
areas; the burden of TB was higher among participants from the lower economic status than
those in the higher wealth status as shown in Table 4.
Table 2. Health seeking and treatment status of survey cases.
Variable N %
Total number of TB survey cases 265 100
Number of TB survey cases who were not on treatment at the time of the interview 258 97.4
Number of TB cases detected by the survey who were already on treatment 7 0.3
Number of TB survey cases who were symptomatic 161 60.6
Number of symptomatic TB survey cases not on treatment at the time of the interview 156 96.9
Number of symptomatic TB cases not on treatment but who sought care 80 49.7
Number of symptomatic TB survey cases not on treatment who sought care at a public facility 74 94
Number of symptomatic TB survey cases not on treatment who sought care at a private
facility
3 4
Number of symptomatic TB survey cases not on treatment who sought care at other facility 3 4
doi:10.1371/journal.pone.0146392.t002
Table 3. Smear, Culture and Bacteriological confirmed TB Prevalence.
Smear Culture Bacteriological
Variable Number of
Survey
Participants
Absolute
number
of survey
cases
Prevalence
per 100,000
95% CI p-
value
Prevalence
per 100,000
95% CI P-
value
Prevalence per
100,000
95% CI P-
value
Overall 46,099 265 319 232–406 568 440–679 638 502–774
Setting
Rural 30,042 120 187 130–243 404 295–513 460 344–577
Urban 16,057 145 583 391–775 <0.001 897 632–1163 <0.001 993 714–1273 <0.001
Sex
Male 19,457 152 445 309–580 726 548–904 833 641–1024
Female 26,642 113 221 139–303 <0.001 446 316–576 <0.001 487 353–621 <0.001
Age
(Years)
15–24 14,702 32 154 71–236 255 129–381 285 157–412
25–34 10,376 66 422 245–599 <0.001 572 362–783 <0.001 664 337–891 <0.001
35–44 8,168 68 496 315–676 <0.001 841 576–1106 <0.001 947 660–1237 <0.001
45–54 5,369 45 323 139–507 0.017 822 517–1127 <0.001 926 611–1240 <0.001
55–64 3,741 23 333 149–517 0.284 663 360–966 0.013 708 401–1013 0.005
65+ 3,743 31 288 91–485 0.006 809 452–1167 0.001 876 535–1218 <0.001
HIV
Status
Negative 28,429 98 182 129–236 336 249–422 387 294–480
Positive 2,062 36 887 424–1350 <0.001 1675 978–2371 <0.001 1726 1029–2423 <0.001
Unknown 14,266 131 499 324–675 <0.001 857 615–1099 <0.001 964 704–1225 <0.001
doi:10.1371/journal.pone.0146392.t003
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Discussion
This is the first nationally representative survey to estimate the burden of TB in Zambia. It is
also the first fully digital national TB prevalence survey conducted world-wide to the best of
our knowledge. Additionally, it is the first national TB survey to concurrently test for HIV
among the survey participants. The survey was conducted in accordance with the WHO guide-
lines [7] on conducting TB prevalence surveys. The participation rate of 84% was by 1% under-
cutting the lower threshold that was aimed at 85%. The slightly lower participation rate was
probably due to the use of large primary sampling units, that is, the CSAs instead of the Stan-
dard Enumeration Areas (SEAs) that were used for Zambia, a vast country with a population
density of about 19 inhabitants per square kilometre. This made it difficult for some potential
participants who had to walk very long distances to get to the survey operations site. The inclu-
sion of HIV testing in this survey may have had a negative impact on the participation rate as
well; nonetheless, the HIV testing was administered at the end of the TB related procedures
with a separate consent. Considering that the HIV testing was offered after the participants had
already participated in the TB processes, we would therefore assume that this did not affect the
participation rate in the TB survey significantly. Studies to explore the effect of inclusion of
HIV testing on participation in TB prevalence surveys are therefore recommended for future
surveys and in other settings.
Other countries which have conducted prevalence surveys before reported varying partici-
pation rates with some reporting higher [8,9,10] while others reported yet lower participation
rates [11,12,13] than the Zambia survey.
Almost all of those who participated underwent the screening process through both the
symptom screening questionnaire interviews and CXR, with only approximately 1% being
screened by interview only. The sputum collection rate was 91%, that is, individuals who sub-
mitted at least one sputum sample out of those who were eligible for sputum examination. The
proportion of survey participants eligible for sputum collection was higher than what was
found in other African countries such as Ethiopia and Nigeria [8, 11].
The prevalence of bacteriologically confirmed MTB was 638 per 100,000 adult population
in 2013–2014. This prevalence of tuberculosis is higher than currently reported by routine sur-
veillance; for instance the notification rate for bacteriologically confirmed TB for the same
period in the age group of 15 years and above was 173 per 100,000 population. Extrapolation of
Table 4. TB prevalence by socioeconomic status for rural and urban.
Variable
Wealth
status
Smear Culture Bacteriological
Number of survey
cases
Prevalence per
100,000
95% CI P-
value
Prevalence per
100,000
95% CI P-
value
Prevalence per
100,000
95% CI P-
value
Rural
Wealth
109
Lowest 42 205 99–310 422 240–603 483 294–672
Middle 45 138 67–209 <0.001 320 196–445 <0.001 364 224–505 <0.001
Highest 22 248 151–345 <0.001 528 358–698 <0.001 610 423–797 <0.001
Urban
Wealth
123
Lowest 7 729 412–1046 1141 685–1597 1208 750–1666
Middle 21 763 468–1057 <0.001 1098 785–1410 <0.001 1251 911–1592 <0.001
Highest 104 359 183–535 <0.001 521 319–723 <0.001 603 386–820 <0.001
doi:10.1371/journal.pone.0146392.t004
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the burden of all forms of TB resulted in a national level prevalence of 455 per 100,000 popula-
tion (range 386-578/100,000) for all age groups in Zambia. This is within the WHO prevalence
estimates for all forms of TB for the same period, which was 338 (193–524) per 100,000 popu-
lation, but with a narrower confidence interval.
The survey has also shown that there are wide variations in the burden of TB by location,
sex, social economic status and age category. The prevalence of MTB was two to three times
higher in the urban than in the rural areas; this was true for all the forms of TB, smear, culture
and bacteriologically confirmed. The risk of TB was higher in males than females in the ratio of
2:1 for all forms; this is consistent with what is normally observed with notifications in data
from the routine surveillance system in this group, and a previous review of routine data indi-
cated consistently higher notifications of males than females over a period of more than ten
years [4]. The survey has also demonstrated the importance of the TB/HIV co–morbidity, with
the HIV positive having a 5 times higher risk of TB than their HIV negative counter parts.
However, there were more participants with TB among the HIV negative individuals compared
to the HIV negative, therefore underscoring the fact that high TB burden of HIV negative indi-
viduals in the communities is equally important.
In terms of socio-economic status using wealth tertiles; the risk of MTB was two times
higher among the highest wealth tertiles than the lowest tertiles in the rural areas. However, the
opposite was true for the urban areas, where the lowest income level reported two times more
TB in the lowest income level than the highest income level.
This survey has also highlighted that MTB cases are likely being missed by routine passive
case finding as most of the symptomatic cases not on treatment had actually even sought care
for their symptoms. Active case finding strategies should be employed in order to improve case
detection and more programmes to inform the general public and communities about the dis-
ease should be considered. More than 90% of TB patients identified during the survey had not
been identified prior to the time of the survey; the reasons for this need to be further investi-
gated, however, the fact that this was a population based survey, most of the patients identified
could have been in the early stages of the disease and hence may not have felt the need to go to
the health facilities to be investigated. On the other hand some of them had sought care at one
point at the health facilities and had not been diagnosed with TB. This could be due to inade-
quate knowledge on the part of the health care providers, therefore, underscoring the urgent
need to ensure that health care providers should be adequately trained in order for them to
have a high index of suspicion in presumptive TB patients. There is a need to sensitize health
workers on ensuring that they provide quality health care services so as to avoid missing cases
which could have otherwise been picked. This presents a pool for perpetuation of the TB bur-
den if it is left unchecked.
The cases of TB were largely occurring between the age group 25–44 years (51%) with the
peak being around the 35–44 age bands; a group which is also economically viable and hence
points to the TB burden having potential economic consequences on the micro and macroeco-
nomic level [14]. This is an important area for future research to estimate the economic conse-
quences of TB especially among the workforce in Zambia. The survey detected more cases in
the age group similar to what is pertaining under routine surveillance [4].
Of the survey cases identified, 49 percent were smear negative, meaning that these cases
could have been missed by routine case detection since it is normally done without culture
identification. However, this finding may even be an underestimation because in some cases
two culture results were not available in significant proportion for the individuals who were eli-
gible for sputum submission. It is therefore important to scale up TB culture laboratory facili-
ties and also investment in better point of care diagnostic approaches is required so that the
chances of missing MTB cases are minimized.
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Additionally, 62 percent of the smear positive cases were actually found not to be MTB as
some of the cases were NTM. It is therefore recommended that smear positivity alone may not
be adequate in the detection of TB patients especially when intensified case finding or active
case detection strategies are employed. More specific point of care tests are required, so that
only true MTB positive cases are put on anti-TB treatment. In fact, there are some studies that
have shown that smear positivity is not a good indicator of MTB disease [8,15].
If only one of the symptoms (lasting two weeks or more) was used to screen potential cases;
84 percent, 57 percent and 53 percent of the survey cases would have missed by fever, cough
and chest pain respectively. Fortunately, in this survey, all the three symptoms were used in
combination or alone to come up with potential survey participants to submit sputum for labo-
ratory investigation. Nonetheless; using symptoms alone; 39 percent of the survey cases could
have gone undetected. The additional 104 out of the 265 cases were detected using chest x-ray
screening. It is also likely that even the bacteriologically negative individuals with abnormal
CXR could later develop TB as has been shown before [16]. Therefore, post-survey follow up of
participants with abnormal CXR is highly recommended.
On the other hand, if only chest-x-ray screening alone was used to identify cases eligible for
sputum submission; 17% of the survey cases would have been missed. The use of an elaborate
symptom screening algorithm resulted in a more robust screening criteria hence minimising
the possibility of missing cases in this survey. This is unlike other surveys, for example Pakistan
[13] and Vietnam [12] used cough only]. It is therefore cardinal to use both symptom screening
in combination with chest x-ray screening so as to optimize the case detection TB prevalence
surveys. Missing of cases would lead to an underestimation of the prevalent cases in a given
country.
Another important feature of the Zambian survey was the use of Xpert for all cases which
were either smear positive or the culture results were inconclusive. This way; 17 additional
cases were detected which could have otherwise gone undetected (Table 1). The Xpert was
especially useful when the only available culture sample was contaminated and CXR was con-
sistent with TB. The role of Xpert in national TB surveys needs to be further evaluated in other
settings.
Through the use of digital systems, the usually anticipated data transcription errors were
minimized through the use of pre-programmed electronic questionnaires, barcoding and scan-
ning thereby leading to efficient and quality data collection. The digital data collection systems
enabled daily monitoring of field operations and the survey teams to receive immediate feed-
back on data quality so that necessary improvements were made on a continuous basis with no
or minimal disruption of field operations. This resulted in high quality data being collected and
real time data checking. The application of technology and digital collection systems also
reduced the time from data collection to reporting of results.
The TB prevalence in the adult population in Zambia in 2014 (638/100,000; range 502-774/
100,000) is similar to what was found in Nigeria in 2014 (524/100,000; range 378-670/
100,000), Myanmar in 2010 (613/100,000; range 502-748/100,000) and Cambodia in 2011
(831/100,000 range 707-977/100,000) but is higher than that of Ethiopia (277/100,000; range
208–347) and Pakistan (296.6/100,000 range 248.1–345.2/100,000) in 2011 [8, 9, 10, 11, 13].
This therefore shows that the burden of TB in Zambia, like in many low income countries, is
very high requiring intensified and innovative TB control strategies [17] without which TB
elimination may not be achieved [18].
The second TB prevalence survey after seven to ten years of intensive implementation of the
National TB control program will be important to measure the difference in the disease burden
and help assess whether or not the global and national target to reduce prevalence has been a
success in Zambia.
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Limitations
It is acknowledged that national prevalence surveys have inherent limitations as information
on paediatric TB (< 15 years old), extra pulmonary TB, smear and culture negative cases is not
collected.
Conclusion
The TB burden in Zambia is higher than previously estimated through routine surveillance.
There is need to improve case detection rates especially among the identified hot spots in the
sub-regions. This survey has also shown that digital systems are feasible. We have also demon-
strated that TB surveys can integrate HIV testing so that the TB/HIV co-morbidity is better
estimated. The application of digital data collection systems is recommended for future
national TB prevalence surveys in order to make data collection more efficient and reduce time
from data collection to results reporting.
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